ライフサイエンスコーパス: laboratory animal

1 iting factor of hepatocytes in commonly used laboratory animals.

2 arch Council's Guide for the Care and Use of Laboratory Animals.

3 sulin-like growth factor I (IGFI) pathway in laboratory animals.

4 and reduces the growth of existing tumors in laboratory animals.

5 gainst carcinogenesis and extend lifespan in laboratory animals.

6 ectivity/cytopathology and pathogenicity for laboratory animals.

7 e and across humans, other natural hosts and laboratory animals.

8 reasingly important to assess mood states in laboratory animals.

9 uating the effects of analgesic compounds in laboratory animals.

10 activity under well-controlled conditions in laboratory animals.

11 es, which have been shown to cause cancer in laboratory animals.

12 found effects on the health and longevity of laboratory animals.

13 utes of Health standards for care and use of laboratory animals.

14 as been found to be a complete carcinogen in laboratory animals.

15 in ticks and tissue samples from humans and laboratory animals.

16 ire the gathering of pharmacokinetic data in laboratory animals.

17 have not elicited neutralizing antibodies in laboratory animals.

18 pment by streamlining preclinical testing in laboratory animals.

19 nduce primary brain cancers and lymphomas in laboratory animals.

20 man subjects, analogous to those reported in laboratory animals.

21 een relatives is well known from captive and laboratory animals.

22 a DNA tumor virus known to induce cancers in laboratory animals.

23 rcinogens, and potent mammary carcinogens in laboratory animals.

24 infect human beings and to induce tumours in laboratory animals.

25 NA vaccines administered to the epidermis of laboratory animals.

26 s also been isolated from a wide spectrum of laboratory animals.

27 presses ethanol intake in alcohol-preferring laboratory animals.

28 sed for long-term studies in immunocompetent laboratory animals.

29 known to impair motor function in humans and laboratory animals.

30 dopamine (DA) terminals when administered to laboratory animals.

31 havior is limited by its apparent absence in laboratory animals.

32 nd progression of atherosclerotic lesions in laboratory animals.

33 DBP and a DNA vaccine were used to immunize laboratory animals.

34 ciated with cognitive deficits in humans and laboratory animals.

35 nderground miners and experimentally exposed laboratory animals.

36 presses ethanol intake in ethanol-preferring laboratory animals.

37 coprivic conditions markedly increase CBF in laboratory animals.

38 tion against a tick-transmitted infection on laboratory animals.

39 gated during insulin-induced hypoglycemia in laboratory animals.

40 f California, Los Angeles, for imaging small laboratory animals.

41 P-induced central nervous system toxicity in laboratory animals.

42 notypes and virulence in cell monolayers and laboratory animals.

43 s enterohepatic disease in many domestic and laboratory animals.

44 sely affected by alcohol abuse in humans and laboratory animals.

45 wn in the modulation of memory in humans and laboratory animals.

46 ting experimental drugs in T. cruzi-infected laboratory animals.

47 ne transporter sites in vitro and in vivo in laboratory animals.

48 many different types of injury in humans and laboratory animals.

49 ollowing the injection of patient blood into laboratory animals.

50 er than ever before and to reduce testing on laboratory animals.

51 ness of the extremities in exposed human and laboratory animals.

52 what is known from classical neuroanatomy in laboratory animals.

53 supporting cellular and molecular studies in laboratory animals.

54 ve been shown to cause neurotoxic effects in laboratory animals.

55 ut alternative to brain tissues excised from laboratory animals.

56 of Health guidelines for the care and use of laboratory animals.

57 n reached in a wide variety of studies using laboratory animals.

58 iance with the Guide for the Care and Use of Laboratory Animals.

59 for consecutive PET and MR imaging of small laboratory animals.

60 d longevity and improve health parameters in laboratory animals.

61 popular technique for tinnitus assessment in laboratory animals.

62 ection techniques for tinnitus assessment in laboratory animals.

63 sidered when imposing husbandry variables on laboratory animals.

64 memory that has been studied extensively in laboratory animals.

65 Service Policy on the Humane Care and Use of Laboratory Animals.

66 e pathophysiologic processes in patients and laboratory animals.

67 Antisera raised in laboratory animals against SD3, SD3+, and SD2+3 inhibite

68 ucts progressively disappear from the DNA of laboratory animals, AL-dA lesions has lasting persistenc

69 anism of action of antidipsotropic agents in laboratory animals, aldehyde dehydrogenase (ALDH) isozym

70 Unlike laboratory animals, all humans are infected with multipl

71 We carried out the health check-up on laboratory animal allergy (LAA) by questionnaires and sp

72 ied on allergic sensitization prevalence for laboratory animals among students and researchers who ar

73 ian cue integration approach been applied to laboratory animals, an important step toward understandi

74 sent review examines the available data from laboratory animal and human intervention studies on tea

75 Included were laboratory animal and human studies relevant to immune f

76 and expensive to obtain-a common problem in laboratory animal and human studies.

77 nstitutes of Health Guidelines on the Use of Laboratory Animals and approved by the Institutional Ani

78 ion of memory, highlighting relevant work in laboratory animals and human subjects.

79 wledge of these properties for commonly used laboratory animals and humans ( 30 g to 150 kg).

80 Investigations in both laboratory animals and humans indicate that cells, organ

81 Experimental studies in laboratory animals and humans suggest that alpha-linolen

82 ion results in diaphragmatic atrophy in both laboratory animals and humans.

83 uences spatial orientation and navigation in laboratory animals and humans.

84 lso causes features of metabolic syndrome in laboratory animals and humans.

85 an minimize a widespread source of stress in laboratory animals and improve welfare through refinemen

86 ce to organ transplants has been reported in laboratory animals and in humans after nonmyeloablative

87 evelopment cause congenital heart defects in laboratory animals and in man.

88 e differences between experimental models in laboratory animals and naturally occurring traumatic inj

89 falciparum sporozoites do not infect common laboratory animals and only develop in vitro in human he

90 otent effects of therapeutic angiogenesis in laboratory animals and the marginal results observed in

91 mental autoimmune encephalomyelitis (EAE) in laboratory animals and the presumed mediators of multipl

92 ed widely to develop human disease models in laboratory animals and to study gene functions by silenc

93 It is also a very useful laboratory animal, and readily lends itself to the trans

94 n produces stress-like effects in humans and laboratory animals, and CRF levels are elevated in indiv

95 gnition, neuroprotection and neurogenesis in laboratory animals, and has entered phase II clinical tr

96 studies with germ-free or antibiotic-treated laboratory animals, and human studies that evaluated how

97 alises the effects of endotoxin in vitro, in laboratory animals, and in humans.

98 Numerous studies document RNAi efficacy in laboratory animals, and the first clinical trials are un

99 Epidemiologic, laboratory, animal, and clinical studies suggest that th

100 ity of the brain of normal, awake humans and laboratory animals are accompanied almost invariably by

101 trophils, macrophages and dendritic cells in laboratory animals are discussed.

102 study the abuse-related effects of drugs in laboratory animals are intravenous drug self-administrat

103 Humans and laboratory animals are thought to discriminate sensory o

104 Among laboratory animals, AS(PV) and ex vivo results were simi

105 NNK and NNAL can induce lung cancer in laboratory animals but human data are limited.

106 othiocyanates inhibit lung carcinogenesis in laboratory animals but human data are limited.

107 at and protect against insulin resistance in laboratory animals, but it is not known whether DHEA dec

108 blood concentrations of thyroid hormones in laboratory animals, but it is unclear whether PBDEs disr

109 mprove the health and extend the lifespan of laboratory animals, but its effect on humans has never b

110 ascular hyperplasia in immunologically naive laboratory animals, but their usefulness for intra-arter

111 ore-than-additive effects on drug seeking in laboratory animals, but, surprisingly, seem to compete w

112 se model inducible in susceptible strains of laboratory animals by immunization with protein constitu

113 tury, malignant skin tumors were produced in laboratory animals by repeatedly painting them with coal

114 are readily self-administered by humans and laboratory animals by virtue of their actions on dopamin

115 Lifespan of laboratory animals can be increased by genetic, pharmaco

116 First, studies of laboratory animals can help to distinguish between healt

117 ibum collected from humans and three typical laboratory animals, canines, mice, and rabbits, for thei

118 by the Institutional Administrative Panel on Laboratory Animal Care at Stanford University.

119 by the Institutional Administrative Panel on Laboratory Animal Care at Stanford University.

120 by the Institutional Administrative Panel on Laboratory Animal Care at Stanford University.

121 by the Institutional Administrative Panel on Laboratory Animal Care.

122 by the Institutional Administrative Panel on Laboratory Animal Care.

123 by the Institutional Administrative Panel on Laboratory Animal Care.

124 by the institutional Administrative Panel on Laboratory Animal Care.

125 were approved by the administrative panel on laboratory animal care.

126 by the institutional administrative panel on laboratory animal care.

127 by the Institutional Administrative Panel on Laboratory Animal Care.

128 ved by the ethical committee of the National Laboratory Animal Center.

129 In farm and laboratory animals, chronic exposure to aflatoxins compr

130 ne release and conditioned drug responses in laboratory animals-could inhibit mesolimbic activation e

131 Laboratory animal data indicate that "activation" and "t

132 Because standard laboratory animal diets contain high levels of folic aci

133 en used as an index of defensive response in laboratory animals during Pavlovian fear conditioning.

134 Handling laboratory animals during test procedures is an importan

135 nding orbital region of prefrontal cortex in laboratory animals encode information regarding the ince

136 tocol using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) approach.

137 including p53 and pRB: The observations from laboratory animal experiments have provided a rationale

138 neurobehavioral deficits in the offspring of laboratory animals exposed to moderate levels of ethanol

139 his conclusion is supported by findings from laboratory animals exposed to nicotine during developmen

140 version to infectious agents is critical for laboratory animal facility disease monitoring.

141 were healthy when maintained in the standard laboratory animal facility.

142 wide variety of immunologic interventions in laboratory animals, few tolerance induction protocols wi

143 ric disorders, such as schizophrenia, and in laboratory animals following specific pharmacological ma

144 nistration behavior has been demonstrated in laboratory animals for almost all other psychoactive dru

145 ancing Science and Elimination of the Use of Laboratory Animals for Development and Control of Vaccin

146 Studies in laboratory animals found that iron deficiency without an

147 tion of the dithiolethione oltipraz protects laboratory animals from the development of tumors follow

148 In laboratory animals, genetics and environment are variabl

149 Routine laboratory animal handling has profound effects on their

150 f behavioral paradigms designed for nonhuman laboratory animals has also had a significant impact on

151 rganisms isolated from the lungs of infected laboratory animals have been developed.

152 Although induced mutations in traditional laboratory animals have been valuable as models for huma

153 hetic ganglia neurons in the lower airway of laboratory animals have membrane properties associated w

154 Epidemiological and model studies with laboratory animals have provided evidence that nonsteroi

155 Studies of laboratory animals have shown that administration of ant

156 idemiologic studies and research findings in laboratory animals have shown the chemopreventive potent

157 Unlike laboratory animals, humans are infected with multiple pa

158 y challenged murine macrophages in vitro and laboratory animals in vivo.

159 edition of the Guide for the Care and Use of Laboratory Animals included new recommendations for the

160 ly purified from a patient with diarrhea, in laboratory animals including chickens, mice, piglets, an

161 tract are described based on observations of laboratory animals including mice, rats and guinea-pigs,

162 ng humans and are absent in the skin of most laboratory animals including rodents, rabbits, and pigs.

163 rs including Alzheimer's disease (AD), while laboratory animals, including animal models of AD, can e

164 s in sleep quality are seen during ageing in laboratory animals, including the fruit fly Drosophila.

165 Evidence in laboratory animals indicates that exposure to stimulants

166 Extensive research with laboratory animals indicates that the hippocampus is cru

167 n a laboratory setting, and the infection of laboratory animals induces robust innate and adaptive im

168 In laboratory animals, intrasplenic hepatocyte transplantat

169 Prospective laboratory animal investigation.

170 Intravenous cocaine intake in laboratory animals is characterized by periods of appare

171 measurement of specific-IgE antibody against laboratory animals is useful for understanding allergic

172 ccordance with the Guide for Care and Use of Laboratory Animals issued by the National Research Counc

173 ephalin increase splenic NK cell function in laboratory animals, it is anticipated that naltrexone tr

174 decreases the self-administration of COC in laboratory animals, it is proposed that the anti-addicti

175 spiratory and skin symptoms from exposure to laboratory animals (LA).

176 and the ethical need to minimise the use of laboratory animals, led us to develop tools to maximise

177 ilitating the primary female sex behavior in laboratory animals, lordosis behavior.

178 ssfully used to assess tinnitus in different laboratory animals, many of the finer details of this me

179 yeblink classical conditioning in humans and laboratory animals may be functionally similar.

180 The main types of tumour induced by SV40 in laboratory animals mirror the human cancers that have be

181 Epidemiological studies and laboratory animal model assays suggest that a high intak

182 Here, we describe a laboratory animal model for M. marinum disease in the le

183 To date, a laboratory animal model for the study of Sin Nombre viru

184 Epidemiological and laboratory animal model studies suggest that the effect

185 The lack of a standardized laboratory animal model that mimics key aspects of human

186 iatric patients, rhesus monkeys are an ideal laboratory animal model to investigate the maturation of

187 barrier (BBB), we performed cross-validating laboratory, animal model, and human brain tissue investi

188 Effective laboratory animal models of CML are needed to study the

189 Patients and laboratory animal models of temporal lobe epilepsy displ

190 the study of bacterial infection dynamics in laboratory animal models.

191 oncogenic potential of this virus in several laboratory animal models.

192 have been conducted with well-characterized laboratory animal models.

193 ccines and evolved viruses for vaccines, and laboratory animal models.

194 o be good orally active antihypertensives in laboratory animal models.

195 al of polyomavirus is primarily evaluated in laboratory animal models.

196 an gastric function may differ from standard laboratory animal models.

197 ed in the very young cartilage obtained from laboratory animals or in porcine and bovine articular ca

198 Although Pitx1 null mutations are lethal in laboratory animals, Pitx1 regulatory mutations show mole

199 Laboratory animals pretreated with antidepressants have

200 In plants and laboratory animals, QTL mapping is commonly performed us

201 cretion by releasing gastrin in a variety of laboratory animals, recent studies were unable to demons

202 atum, and increasing D(2) receptor levels in laboratory animals reduces alcohol consumption.

203 l differences in these responses are seen in laboratory animals, related in part to input from the pr

204 In laboratory animals, repeated administration of drugs of

205 ), acute hepatitis E patients (n = 94), five laboratory animals (rhesus monkey, pig, New Zealand rabb

206 ode Caenorhabditis elegans, which block this laboratory animal's feeding.

207 zed rats with the ATLAS (Advanced Technology Laboratory Animal Scanner) small animal PET scanner deve

208 in the current Guide for the Care and Use of Laboratory Animals should be reconsidered.

209 s enterohepatic disease in many domestic and laboratory animal species.

210 However, laboratory animal spinal cord injury cannot accurately m

211 Human clinical studies as well as laboratory animal studies demonstrate that offspring of

212 Laboratory animal studies have shown that parabens posse

213 Although laboratory animal studies have shown that the amygdala p

214 Laboratory animal studies of Pavlovian fear conditioning

215 Laboratory animal studies of substance P suggest a facil

216 literature from the last 40 years reporting laboratory animal studies pertaining to the persistent e

217 In a randomized, nonblinded laboratory animal study conducted between January 2013 a

218 In a randomized, nonblinded laboratory animal study, rats were randomized into a con

219 s carried out using either human subjects or laboratory animals suggest that vitamin D and its analog

220 n establish conditioned place preferences in laboratory animals, suggest that these drugs activate bi

221 hese results are consistent with findings in laboratory animals, suggesting that differences in sexua

222 The observation of this phenomenon in older laboratory animals suggests that physiological changes p

223 denoviral vectors are typically performed in laboratory animals that lack immunity to adenovirus.

224 dated using clinical samples from humans and laboratory animals that were known to be infected with p

225 ment of drug seeking is reliably observed in laboratory animals that were trained to self-administer

226 ism and blood pressure control of humans and laboratory animals, the focus is on human studies.

227 Of the commonly used laboratory animals, the rabbit is the only one in which

228 s of NMDA antagonist treatment in humans and laboratory animals, there is a fundamental lack of under

229 of the evidence at present is limited to the laboratory animals, this approach seems to hold a promis

230 Among laboratory animals, this tiny nematode is one of the sim

231 mulative neurotoxicity in exposed humans and laboratory animals through a direct inhibitory effect on

232 ing of core temperature during anesthesia in laboratory animals to avoid artifactual elevation of pro

233 raised concerns because it has been shown in laboratory animals to be neurotoxic to dopamine terminal

234 asma concentrations of anticancer drugs from laboratory animals to humans and among humans of differe

235 immunity by selective microbial exposure of laboratory animals to mimic that of humans.

236 e been shown to exacerbate the propensity of laboratory animals to spontaneously develop cardiodegene

237 AS and MP in 126 consecutive patients and 10 laboratory animals undergoing CMR.

238 that can reproduce these LC abnormalities in laboratory animals, we hypothesized that noradrenergic p

239 proach for screening an inbred population of laboratory animals, we identified two subpopulations of

240 Enhancing laboratory animal welfare, particularly in rodents, has

241 All procedures using laboratory animals were approved by the Institutional Ad

242 of Health guidelines for the care and use of laboratory animals were observed.

243 All procedures in which laboratory animals were used were approved by the instit

244 mune dysfunction, and increased infection in laboratory animals, whereas elemental diets, with or wit

245 urinary output, and renal histopathology in laboratory animals with acute renal dysfunction.

246 ch is protective against lethal challenge of laboratory animals with Coccidioides immitis, was fracti

247 ain reliable self-administration behavior by laboratory animals with delta-9-tetrahydrocannabinol (TH

248 contrast sexual differentiation in standard laboratory animals with differentiation in species exhib

249 yte transplantation improves the survival of laboratory animals with experimentally induced acute liv

250 establishes respiratory tract infections in laboratory animals with high efficiency.

251 On the basis of successful vaccination of laboratory animals with living irradiated, third-stage h

252 Vaccination of laboratory animals with recombinant Na-ASP-2 provides si

253 time course of onset of opiate dependence in laboratory animals, with the mathematical time course of

254 Further research on laboratory animals would be necessary to verify these ch